← back to search

Edoardo Savarino

Amsterdam University Medical Centers · IT
Area of research
Surgery · Gastroenterology
Research interest
Research interests include Gastroesophageal reflux and treatments, Eosinophilic Esophagitis, Inflammatory Bowel Disease, and Helicobacter pylori-related gastroenterology studies.
h-index
85
citations
32,669
works
1,379
NIH funding
primary concept
email

Recent publications

The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric Junction.
2026cited by 10position: contributordoi
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota.
2026cited by 7position: contributordoi
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study
Clinical Gastroenterology and Hepatology 2026cited by 4position: contributordoi
Letter: Intestinal Ultrasound: The Evidence Is Catching Up With the Technology.
2026cited by 3position: contributordoi
Pathophysiology of Gastroesophageal Reflux Disease.
2026cited by 3position: contributordoi
The Milan Score is an Effective Manometric Tool to Predict Gastroesophageal Reflux in Patients With Laryngopharyngeal Symptoms.
2026cited by 2position: contributordoi
Transcultural adaptation and validation of the Italian version of the "Adult eosinophilic esophagitis quality of life questionnaire".
2026cited by 1position: contributordoi
Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity.
2026cited by 1position: contributordoi
Letter: Double-Dose Hepatitis B Vaccination in IBD-A Step Forward in Protecting Immunosuppressed Patients.
2026cited by 1position: contributordoi
Letter: Rifaximin Versus Low FODMAP Diet in IBS: What the Primary Endpoint Does Not Tell Us.
2026cited by 1position: contributordoi
Bridging the Gap: From Clinic to Home in IBD Monitoring.
2026cited by 1position: contributordoi
Research gaps in eosinophilic esophagitis: unanswered questions and future directions.
2026cited by 1position: contributordoi
Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional Perspective.
2026cited by 1position: contributordoi
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.
2026cited by 1position: contributordoi
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
2026cited by 1position: contributordoi
Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for erosive esophagitis: a network meta-analysis of randomized controlled trials
eClinicalMedicine 2026cited by 1position: contributordoi
Post-Stroke Oropharyngeal Dysphagia: A Clinical Approach to Diagnosis and Management.
2026cited by 0position: contributordoi
Self-management of reflux-like symptoms: A patient-centered decision-making approach.
2026cited by 0position: contributordoi
Potassium-competitive acid blockers for the management of gastroesophageal reflux disease.
2026cited by 0position: contributordoi
The role of mediterranean diet and highly processed foods in inflammatory bowel diseases.
2026cited by 0position: contributordoi
Comment on: Diagnostic accuracy of mean nocturnal basal impedance and other complementary tests for the diagnosis of gastroesophageal reflux disease according to the new Lyon criteria.
2026cited by 0position: contributordoi
Author's Reply: "Comment on ``Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota''.
2026cited by 0position: contributordoi
Author's reply: Comment on "impact of oral butyrate on clinical and biochemical parameters in IBD".
2026cited by 0position: contributordoi
Author's Reply: "Oral Butyrate in IBD: From enterotype stratification to a multi-omic and long-term clinical dialogue".
2026cited by 0position: contributordoi
Author's Reply: "Reconsidering the clinical implications of oral butyrate supplementation in inflammatory bowel disease".
2026cited by 0position: contributordoi
Dietary and nutraceutical interventions for functional dyspepsia: A narrative review.
2026cited by 0position: contributordoi
The Economic Impact of Loss to Follow-Up in Eosinophilic Esophagitis: A Model-Based Analysis from the Perspective of Italian National Health Service.
2026cited by 0position: contributordoi
Blood Eosinophils Are Accurate Biomarkers for the Management of Eosinophilic Oesophagitis: Prospective, Multi-Centre Study.
2026cited by 0position: contributordoi
Protective Effects of Grapeseed Proanthocyanidins in Ulcerative Colitis: A Pilot Study Evaluating a Potential Therapeutic Strategy.
2026cited by 0position: contributordoi
Concomitant 5-Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis.
2026cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 221 papers (2019–2026)Fabiana Zingone · Aziende Socio Sanitaria Territoriale Rhodense114 papers (2019–2026)Nicola de Bortoli · University of Padua88 papers (2012–2025)Brigida Barberio · University of Padua69 papers (2019–2026)Vincenzo Savarino · University of Padua68 papers (2012–2025)C. Prakash Gyawali · Jewish Hospital64 papers (2016–2026)Elisa Marabotto · Swedish Medical Center62 papers (2012–2026)Salvatore Tolone · University of Padua46 papers (2015–2025)Marzio Frazzoni · University of Padua45 papers (2014–2025)Matteo Ghisa · University of Padua44 papers (2018–2025) · 41 papers (2019–2026)Mentore Ribolsi · Università Campus Bio-Medico39 papers (2014–2025)Nicola de Bortoli · University of Pisa33 papers (2019–2026)Pierfrancesco Visaggi · University of Pisa31 papers (2021–2026)Manuele Furnari · University of Padua31 papers (2013–2025)Luisa Bertin · University of Padua29 papers (2024–2026)Vincenzo Savarino · Ospedale Policlinico San Martino28 papers (2019–2026) · 28 papers (2013–2025)Sabine Roman · Université Claude Bernard Lyon 127 papers (2015–2024)Pierfrancesco Visaggi · St Thomas' Hospital26 papers (2020–2025)